GLP-1 drugs could help prevent 34,000 heart attacks and strokes in the US each year, research suggests
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
What Experts Think About Lemme's New GLP-1 Supplement
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
ENDPOINTS NEWS1h
Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?
This week, a letter surfaced in which Eli Lilly asked for a patient to release medical information so it could contact her ...
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
STAT1d
Long-overlooked scientist shares Lasker Award with other GLP-1 researchers
GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
Convenience Store News1d
GLP-1 Drugs Are Changing the Dynamics of the Shopping Basket
The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...
Futurism on MSN3d
Kourtney Kardashian Is Selling a Scam Weight Loss Treatment That Says "GLP-1" on the Bottle But Isn't a GLP-1
As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) ...
Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...